CISPLATINA ACCORD 1mg / ml perfusive solution concentrate medication leaflet

L01XA01 cisplatin • Antineoplastic and immunomodulating agents | Other antineoplastic agents | Platinum compounds

Cisplatin is a chemotherapy medication used for the treatment of various types of cancer, including testicular, ovarian, bladder, and lung cancer. It works by binding to the DNA of tumor cells, inhibiting their replication and inducing cell death.

The medication is administered intravenously, as directed by a doctor, usually in a hospital or specialized clinic. It is important for patients to be monitored to prevent severe side effects.

Patients should be aware of potential side effects, such as nausea, vomiting, kidney dysfunction, or ototoxicity. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, vomiting, and fatigue. In rare cases, severe reactions such as kidney failure or hearing loss may occur. Patients should be informed of these risks before starting treatment.

General data about CISPLATINA ACCORD 1mg / ml

Substance: cisplatin

Date of last drug list: 01-06-2025

Commercial code: W65790003

Concentration: 1mg / ml

Pharmaceutical form: perfusive solution concentrate

Quantity: 1

Product type: generic

Price: 60.50 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ACCORD HEALTHCARE LIMITED - MAREA BRITANIE

Holder: ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA

Number: 8982/2016/03

Shelf life: 3 years

Pharmaceutical forms available for cisplatin

Concentrations available for cisplatin

0.5mg/ml, 10mg, 10mg/20ml, 1mg/1ml, 1mg/ml, 25mg/50ml, 50mg, 50mg/100ml

Other substances similar to cisplatin

Compensation lists for CISPLATINA ACCORD 1mg / ml ACCORD

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

60.50 RON

60.50 RON

0.00 RON

NHP 9.1 (C2) - Spinal cord transplant

Price

Copayment

Patient

60.50 RON

60.50 RON

0.00 RON